Chi-Med’s CEO, Christian Hogg, delivered a confident and convincing presentation at the recent interim analyst meeting. It was certainly refreshing to hear a CEO explain a drop in profits (and doing so succinctly) without blaming “Brexit”. H1 2016 results reflected a period of significant transformation within the business. Group revenues were up 27% to $104.5m with net income at $500k. The company has remained profitable despite a $36m innovation investment programme and a
03 Aug 2016
Chi-Med – David becoming Goliath
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Chi-Med – David becoming Goliath
HUTCHMED (China) Limited (HCM:LON) | 266 0 0.0% | Mkt Cap: 2,322m
- Published:
03 Aug 2016 -
Author:
Niall Pearson -
Pages:
5
Chi-Med’s CEO, Christian Hogg, delivered a confident and convincing presentation at the recent interim analyst meeting. It was certainly refreshing to hear a CEO explain a drop in profits (and doing so succinctly) without blaming “Brexit”. H1 2016 results reflected a period of significant transformation within the business. Group revenues were up 27% to $104.5m with net income at $500k. The company has remained profitable despite a $36m innovation investment programme and a